Close
 Indian J Med Microbiol  
 

Figure 2 (A-E): A 56-year-old male with NSCLC. (A) Pre-RFA PET-CT scan (Siemens Healthcare, Knoxville, Tennessee, USA) shows a lung nodule measuring 1.4 × 1.4 cm in the right lower lobe, SUV 4.9 (white arrow) (B) CT-guided RFA performed using an RF ablation system (Boston Scientific, Natick, MA, USA) (C) A large area of GGO is seen around the nodule immediately after ablation (D) PET-CT performed the next day shows GGO around the nodule. However, there is resolution to background of the fluorodeoxyglucose (FDG) activity (white arrow) (E) CT follow-up at 3 months shows residual GGO, but no obvious increase in the solid aspect of the nodule

Figure 2 (A-E): A 56-year-old male with NSCLC. (A) Pre-RFA PET-CT scan (Siemens Healthcare, Knoxville, Tennessee, USA) shows a lung nodule measuring 1.4 × 1.4 cm in the right lower lobe, SUV 4.9 (white arrow) (B) CT-guided RFA performed using an RF ablation system (Boston Scientific, Natick, MA, USA) (C) A large area of GGO is seen around the nodule immediately after ablation (D) PET-CT performed the next day shows GGO around the nodule. However, there is resolution to background of the fluorodeoxyglucose (FDG) activity (white arrow) (E) CT follow-up at 3 months shows residual GGO, but no obvious increase in the solid aspect of the nodule